|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/5377 | (2006.01) |
| A61K 31/4412 | (2006.01) | ||
| A61K 31/444 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3157527 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15809540.6 |
| Date of filing the European patent application | 2015-06-17 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-24 |
| (46) | Date of publication of the claims translation | 2023-07-25 |
| (86) | Number | PCT/US2015/036310 |
| Date | 2015-06-17 |
| (87) | Number | WO 2015/195848 |
| Date | 2015-12-23 |
| (30) | Number | Date | Country code |
| 201462013522 P | 2014-06-17 | US | |
| 201462036265 P | 2014-08-12 | US |
| (72) |
KEILHACK, Heike , US
OTTESEN, Lone , GB
REYDERMAN, Larisa , US
JOHNSTON, L. Danielle , US
KNUTSON, Sarah K. , US
|
| (73) |
Epizyme, Inc. ,
400 Technology Square, 4th Floor, Cambridge, MA 02139,
US
Eisai R&D Management Co., Ltd. , 6-10, Koishikawa 4-chome, Bunkyo-ku, Tokyo 112-8088, JP |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | EZH2 inhibitoriai, skirti limfomos gydymui |
| EZH2 INHIBITORS FOR TREATING LYMPHOMA |
| Payment date | Validity (years) | Amount | |
| 2024-05-20 | 10 | 231.00 EUR |
| 2025-06-17 |